Immunohistochemistry using whole mount preparations of the murine mesentery revealed two types of LYVE-1-immunoreactive cells with dendritic morphology other than F4/80 + typical macrophages. The two types of LYVE-1 + cells were regularly distributed with constant intervals throughout the mesentery and appeared to possess their own territory. Both types of LYVE-1 + cells were weakly or moderately immunopositive for F4/80 antibody, a marker of macrophages, while F4/80 + round macrophages were absolutely free from the LYVE-1 immunoreactivity. Only macrophages could ingest latex particles of 20 nm in diameter 3 h after a peritoneal injection. Peritoneal administration of lipopolysaccharide (LPS) induced a rapid reduction of LYVE-1 immunoreactivity in the cells with dendritic morphology followed by an increased immunoreactivity to F4/80 antibody, and simultaneously by dynamic changes in their shape. Under normal conditions, F4/80 + macrophages in various connective tissues expressed LYVE-1, in contrast to lack of LYVE-1 in F4/80 + macrophages within the parenchyma of visceral organs and macrophages residing in hepatic sinusoids and pulmonary alveoli. LYVE-1 may play a role in cell adhesion and migration of macrophagic cells within connective tissues rich in hyaluronan, and loss of LYVE-1 becomes a reliable sign of activated conditions in inflammation.
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Membranous tissues such as the omentum and mesentery contain many macrophages and related cells, including Langerhans/dendritic cells. However, their distinct classification and functions remain unclear. As shown by their stainability with marker antibodies and enzymatic activities, cells with dendritic morphology in the rat omentum were very close to Ia antigen-positive interdigitating cells of lymphatic tissues (9) . This study also noted that cells with dendritic morphology in the rat omentum were fairly heterogeneous (9) . Zhu et al. (23) recognized the stellate or dendritic cells in the mouse omentum to be scavenging macrophages due to their phagocytic activity, stainability to marker antibodies, and severe reduction in number in op/op mice. The omental dendritic cells are slender or stellate in shape, projecting long cytoplasmic processes, while typical macrophages are round in shape. Furthermore, the dendritic cells are embedded in the connective tissue of the omentum, in contrast to round macrophages being exposed to the peritoneal cavity. The somewhat confusing classification and terminology of cells with dendritic morphology in the omentum may be partially due to the use of different marker antibodies and sampling under different conditions. Since macrophages or dendritic cells in membranous tissues facing the peritoneal cavity have quite a large population and play an important role in homeostasis of the peritoneal cavity, they should be classified more exactly as they are related to their diverse functions. LYVE-1 (lymphatic vessel endothelial hyaluronan receptor) is useful as a marker of the lymphatic endothelium (10, 12, 17) . LYVE-1 is a transmembrane air-dried. Lipopolysaccharide (LPS, 0.02 mg/20 g body weigh) (E. coli 055:B5, Sigma Aldrich) was injected into the peritoneal cavity, and the mesentery was obtained at 1 and 2 days after the injection (n = 3 for each time point). Latex particles of 20 nm in diameter (FluoSpheres, carboxylate-modified, red [580/605]; Life Technologies, Eugene, OR) were injected at a dose of 100 μL diluted by 400 μL saline, and the mesentery was obtained 3 h, 1 day, and 2 days after injection (n = 3 for each time point). All experiments using animals were performed under protocols following the Guidelines for Animal Experimentation, Hokkaido University Graduate School of Medicine. Using the whole mount preparations mentioned above, fixation was done with 10% formalin in 0.1 M phosphate buffer (pH 7.4) for 2 h. The specimens were then immersed in 0.01 M phosphate buffered saline (PBS) containing 0.3% Triton-X100 for 1 h to enhance the penetration of antibodies and in 100% ethanol for 30 min to remove lipid from the samples. For conventional immunohistochemistry using cryostat sections, another five mice were perfused with a physiological saline through the heart under deep anesthesia, followed with 4% paraformaldehyde in 0.1 M phosphate buffer. The liver, lymph node, thymus, spleen, interscapular brown adipose tissue, ovary, kidney, adrenal gland, brain, and mesentery were dissected out and immersed in the same fixative for an additional 6 h. The fixed tissues were dipped in 30% sucrose overnight at 4°C, embedded in OCT compound (Sakura FineTechnical Co. Ltd., Tokyo, Japan), and quickly frozen in liquid nitrogen. Frozen sections of a 10 μm thickness were mounted onto poly-L-lysine-coated glass slides and immersed in PBS containing 0.3% Triton-X100 for 1 h.
Immunohistochemistry of LYVE-1 and F4/80. Cryostat sections on glass slides were pretreated with 0.03% H 2 O 2 in methanol to block the endogenous peroxidase activity. They were further pretreated with a normal goat serum and incubated with a rabbit anti-mouse LYVE-1 antibody (AngioBio, Del Mar, CA) at a concentration of 1 μg/mL overnight. The sites of the antigen-antibody reaction were detected by incubation with biotin-conjugated goat anti-rabbit IgG (Nichirei, Tokyo, Japan), followed by incubation with the avidin-peroxidase complex (Vectastain ABC kit; Vector, Burlimgame, CA). The reactions were visualized by incubation in 0.05 M Tris-HCl buffer (pH 7.6) containing 0.01% 3,3'-diaminobenzidine and 0.001% H 2 O 2 .
glycoprotein that contains a hyaluronan-binding domain to bind and immobilize this common extracellular matrix molecule (3, 18) . Hyaluronan undergoes rapid turnover with a half-life of ~24 h, and more than 80% of tissue hyaluronan is degraded within the lymph nodes (6, 7, 13) . Immunohistochemistry for LYVE-1 can specifically detect lymphatic vessels in various tissues where the receptor is engaged in the transport of hyaluronan into the vessel lumen (18) . LYVE-1 had been regarded a key receptor responsible for the uptake and transport of hyaluronan in the lymph circulation. However, subsequent studies using knock-out mice showed that the expression of LYVE-1 in the lymphatic endothelium is dispensable for hyaluronan metabolism (10, 11) . Besides lymphatic endothelial cells, the hepatic sinusoidal endothelium and some populations of macrophages express LYVE-1 (8, 15) . LYVE-1 is expressed in typical CD11b
+ macrophages in peri-tumour connective tissue, and in wound healing tissues of mice (19) . Another LYVE-1 immunoreactivity is found in human fetal macrophages within the chorion villi of the placenta (5) as well as in the murine fetal macrophages in the developing kidney (14) . The expression of LYVE-1 by macrophages suggests functions other than the transport of tissue hyaluronan into lymph circulation: 1) the uptake and degradation of hyaluronan, 2) cell adhesion and migration in the extracellular matrix, and 3) regulation of inflammation. Our preliminary study of the murine mesentery using an antibody against LYVE-1 stained a great number of specialized cells which possessed long processes, were distributed in equal spaces, but differed from F4/80 + typical macrophages. The present immunohistochemical study using a LYVE-1 antibody and macrophage markers discriminates two types of cells with dendritic processes as well as typical macrophages in the murine mesentery. These cells were observed more clearly and broadly by using whole mount preparations of the mesentery and were compared with macrophages for their shape, distribution, ultrastructure, and uptake ability.
MATERIALS AND METHODS
Tissue samples of mesentery. Adult female ddY mice, weighing about 25-28 g, were used in this study. The mice were sacrificed by bloodletting from the heart under deep anesthesia with pentobarbital sodium. Pieces of fresh mesentery tissues were collected, mounted as a sheet on glass slides, and
RESULTS

Immunohistochemistry of LYVE-1 and F4/80 in mesentery
Observation of whole mount preparations of the mesentery revealed the entire shape and distribution of LYVE-1-immunoreactive cells (LYVE-1 + cells). Intensely immunoreactive cells for LYVE-1 were evenly distributed throughout the mesentery and projected thick processes (Fig. 1a) . They usually projected two or three processes which extended in opposite or triangular directions (Fig. 1c, + cells appeared to be wholly embedded in membranous tissues of the mesentery (Fig. 1d) . These two types of LYVE-1 + cells were weakly or moderately positive for F4/80, a marker of murine macrophages, as compared to round macrophages with an intense labeling (Fig. 2a, b) . Interestingly, two types of LYVE-1 + cells were segregated, possessing their own territory of distribution (Fig. 1c) . Immunohistochemistry using the F4/80 antibody detected typical round macrophages with uneven distribution: they often aggregated in some places of the mesentery (Fig. 2a, b) . These macrophages were absolutely negative in reaction for LYVE-1. Immunostaining of CD11c, a marker of dendritic cells, failed to stain both LYVE-1 + cells with dendritic morphology and F4/80 + macrophages (data not shown).
Uptake of exogenous particles
When fluorescent latex particles of 20 nm in diameter were injected into the peritoneal cavity, only F4/80 + macrophages vigorously ingested the latex particles at 3 h after the injection; no LYVE-1 + cells contained latex particles in their cytoplasm (Fig. 2c) . However, a moderate uptake of latex particles by LYVE-1 + cells was found at 1 or 2 days after the injection (data not shown).
Response to inflammation induced by LPS
Injection of LPS into the peritoneal cavity induced dynamic changes in LYVE-1 + cells of the mesentery. At 1 and 2 days after the LPS challenge, most of the LYVE-1 + cells had lost the immunoreactivity to the LYVE-1 antibody and come to be more intensely immunoreactive for F4/80 as compared with normal conditions (Fig. 2d) . Also, two types of For immunofluorescence, samples were pretreated with normal donkey serum and incubated with a rabbit anti-LYVE-1 antibody (2 μg/mL) overnight, followed by incubation with Cy3-labeled anti-rabbit IgG (1 : 200 in dilution; Jackson ImmunoResearch, West Grove, PA). For double immunofluorescence of whole mount preparations and tissue sections, the samples were pretreated with normal donkey serum and incubated with a mixture of rabbit anti-LYVE-1 (2 μg/mL) and rat anti-F4/80 antibodies (Clone CI:A3-1 or BM8, 1 μg/mL; BioLegend, San Diego, CA) overnight. The sites of the antigen-antibody reaction were detected by incubation for 2 h with Cy3-labeled anti-rat IgG (Jackson ImmunoResearch) and AlexaFluor 488-labeled anti-rabbit IgG (Invitrogen, Carlsbad, CA). Stained samples were mounted with glycerin-PBS and observed under a confocal laser scanning microscope (Fluoview; Olympus, Tokyo, Japan). Some of immunostained sections were counterstained with SyTO 13 (Invitrogen) for observation of the nuclei.
Immunoelectron microscopy. We used two different methods for electron microscopic observation of LYVE-1-immunoreactive cells in the mesentery. After blocking the endogenous peroxidase activity, paraformaldehyde-fixed cryostat sections were pretreated with normal goat serum for 1 h and incubated with the rabbit anti-LYVE-1 antibody (1 μg/mL) overnight. Following washing, they were incubated with peroxidase-labeled anti-rabbit IgG (Dako Japan, Tokyo) for 3 h. The antigen-antibody reactions were detected by incubation in 0.05 M Tris-HCl buffer (pH 7.6) containing 0.01% 3,3'-diaminobenzidine and 0.001% H 2 O 2 , and post-fixed in 1% OsO 4 for 30 min. The specimens were dehydrated through a graded series of ethanol and directly embedded in Epon (Nisshin EM, Tokyo, Japan). For the silver-intensified immunogold method, the fresh mesentery mounted on glass slides was fixed in 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 for 2 h. After preincubation with normal goat serum, the specimens were incubated with the anti-LYVE-1 antibody (3 μg/mL) overnight and subsequently reacted with goat anti-rabbit IgG covalently linked with 1-nm gold particles (1 : 200; Nanoprobes, Yaphank, NY). Following silver enhancement using a kit (HQ silver; Nanoprobes), the sections were osmicated, dehydrated, and directly embedded in Epon (Nisshin EM). Ultrathin sections were prepared and stained with both uranyl acetate and lead citrate for observation under an electron microscope (H-7100; Hitachi, Tokyo, Japan). der the electron microscope (Fig. 3a) . The LYVE-1 + cells contained vesicles of various sizes as well as rough endoplasmic reticulum and Golgi apparatus. By the immunogold method, LYVE-1 + cells in whole mount preparations were heavily labeled with gold particles (Fig. 3b) . LYVE-1 + cells displayed complicated contours and were embedded by collagen fibrils. The LYVE-1 immunoreactivity detected by the two methods was found mainly in the cyto-LYVE-1 + cells, now visualized only by the F4/80 antibody, changed their morphology (Fig. 2e, f) . Especially, Type 1 LYVE-1 + cells elongated to extend long and slender processes in many directions, similar to astroglia in the brain (Fig. 2e) .
Ultrastructure LYVE-1-positive cells within the mesentery were identified by a heavy labeling of osmium black un- plasm but were more intense near the plasma membrane.
LYVE-1 immunoreactivity in macrophages of other organs
In contrast to mesentery F4/80 + macrophages, F4/80 + macrophages dispersed in various connective tissues intensely expressed LYVE-1. In the joint, macrophages in the synovial membrane (type A synoviocytes) and in the deeper region of the synovium were immunoreactive for both LYVE-1 and F4/80 (data not shown). The capsules and interstitium of the kidney (Fig. 4a) , brown adipose tissue, thymus, and lymph node contained LYVE-1 + F4/80 + cells. Although F4/80 + cells were rich in the parenchyma of these organs, they were absolutely free from LYVE-1 immunoreactivity. Brain F4/80 + macrophages (microglia) were not immunoreactive for LYVE-1, and 
DISCUSSION
LYVE-1-immunoreactive macrophages embedded in connective tissues
Several types of macrophages share the LYVE-1 molecule with lymphatic endothelial cells. LYVE-1 is expressed in typical CD11b + F4/80 + macrophages dispersed in the connective tissue around tumors and in wound healing tissues (19) . Fetal macrophages in the human placenta and murine kidney are also LYVE-1-immunoreactive (5, 14) , though macrophages in the kidney of adult mice lose this immunoreactivity (14) . The present study revealed a broad distribution of LYVE-1 + macrophages in adult animals under normal conditions. LYVE-1-immunoonly F4/80 + macrophages dispersed in the pia mater stained positively for LYVE-1 (Fig. 4b) . The ovary contained numerous F4/80 + macrophages-especially rich in the corpus luteum, but again these macrophages were immunonegative for LYVE-1 (Fig. 4c) . Hepatic sinusoidal macrophages (Kupffer cells), alveolar macrophages, and macrophages numerous in the medulla of the lymph node and red pulp of the spleen were all negative for LYVE-1. F4/80 + macrophages occupying the lamina propria of the small intestine were also immunonegative for LYVE-1 (Fig. 4d) . The LYVE-1-immunonegative macrophages mentioned above are regarded as resident and non-fixed macrophages which are not embedded in the connective tissues. scaffolds of macrophages for cell adhesion to the extracellular matrix.
LYVE1
+ macrophagic cells in the mesentery Macrophages with dendritic morphology in the omentum of mice were F4/80-and Ia antigen-positive and showed a spindle, dendritic, or stellate shape (23) . The number of omental macrophages was severely reduced in op/op mice, which were genetically deficient in a macrophage lineage (23) . Similarly, ED2-positive spindle-shaped macrophages in the rat omentum were completely eliminated by the uptake of liposome-encapsulated clodronate, a toxic substance (4) . Those cells with dendritic morphology in the murine omentum were negative for markers for Langerhans/dendritic cells (23) , in agreement with the lack of immunoreactivity for CD11c in the present study. These findings suggest that the cells in question are macrophagic in origin rather than Langerhans/dendritic/interdigitating cells. However, our cells in the murine mesentery differed in both shape and immunoreactivity to F4/80 and LYVE-1 antibodies from typical macrophages. The reactive F4/80 + macrophages were dispersed in various connective tissues of the visceral organs, such as the capsule and interstitium of the kidney, thymus, lymph node, and brown adipose tissue. However, none of the F4/80 + macrophages present in the parenchyma of the kidney, thymus, or brain expressed LYVE-1. This lack of LYVE-1 expression was consistent in macrophages residing in hepatic sinusoids, pulmonary alveoli, medulla of the lymph node, and red pulp of the spleen. These LYVE-1-negative macrophages are not embedded in the connective tissue and may lack an intimate relation to the extracellular matrix. It is hard to conclude that LYVE-1 − macrophages in the lamina propria of intestinal villi are embedded in the collagen-rich connective tissue. Collectively, only macrophages anchored in the connective tissue tend to express the hyaluronan-binding molecule, LYVE-1. Hyaluronan is ubiquitously and most abundantly present in the extracellular matrix of tissues where it interacts with numerous proteins to form a hygroscopic matrix important for cell adhesion and migration. Thus, it is likely that LYVE-1 plays a role in the formation of to an inflammatory environment. We confirmed similar changes in mesenteric dendritic cells with a peritoneal injection of Freund' adjuvant (our unpublished data). These changes compare with the finding that pro-inflammatory cytokines such as TNFα induce a rapid internalization of LYVE-1 in lymphatic endothelial cells followed by terminal degradation in lysosomes (11) . Another down-regulation of the hyaluronan receptor was noted in lymphatic vessels during the early stages 24-48 h after mycoplasma infection (11) . LYVE-1 is also lost from sinusoidal endothelial cells of the liver during inflammation (1) and from lymphatic vessels in the early phase of some murine models accompanied with muscle degeneration and inflammation, possibly due to the induction of TNFα (20) . On the other hand, high molecular weight hyaluronan modulates inflammatory responses in macrophages: it inhibits LPS-induced inflammatory signalings in macrophages and microglia (2, 16, 21, 22) . This action was explained by the interaction of hyaluronan with another hyaluronan receptor, CD44, which shares 41% homology with LYVE-1 (16) . Although any direct interaction of hyaluronan with LYVE-1 is unknown, the loss of LYVE-1 in macrophagic cells of the mesentery may be involved in the activation of inflammatory responses. In fact, Wardrop and Dominov (20) described how the disappearance of LYVE-1 in lymphatic vessels provides a sensitive biomarker to monitor active inflammatory or tissue damages.
In conclusion, LYVE-1 is a powerful marker to study the morphology and functional significance of the cells with dendritic morphology in the mesentery. Their characteristic morphology and quick response to an LPS challenge shown by the present study suggest their important roles in the maintenance of the peritoneal cavity and organs. REFERENCES F4/80-intensely positive macrophages of the mesentery are round in shape, negative for LYVE-1, and exposed to the peritoneal cavity. Since the F4/80 + round cells only can vigorously ingest foreign bodies like latex particles, they function as typical scavenger macrophages. The phagocytic activity of omental dendritic cells is very low 3 h after an intraperitoneal injection of colloidal carbons, but one day after administration, they actively ingested carbon particles (23) . We also found that mesenteric LYVE-1 + cells can ingest latex particles to some degree one day after injection. This suppressed ability to ingest foreign particles may be due to their being embedded in membranous tissues. 
Involvement of LYVE1
+ cells in inflammation It was remarkable that the mesenteric dendritic cells almost lost their LYVE-1 immunoreactivity as well as undergoing morphological changes by an LPS challenge, demonstrating their sharp responsiveness
